Testing effectiveness (Phase 2)Looking for participantsNCT07033819
What this trial is testing
Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib
Who this might be right for
Ovarian Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 48